We report that MYC and MYCN show consistently different dependence on MDM2 in cancer cell lines, yet similar abilities to induce MDM2 expression and MDM2-dependent proliferation in the retinoblastoma cell of origin. The gene discussed is MDM2; the disease is retinoblastoma.